ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,740.09
0.38%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) News

BNTX

BioNTech (BNTX)

BioNTech SE
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTX
DateTimeSourceHeadlineSymbolCompany
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
06/01/202410:00AMBusiness WireInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
05/29/20248:00AMGlobeNewswire Inc.BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine EcosystemNASDAQ:BNTXBioNTech SE
05/26/20248:00PMPR Newswire (US)MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnershipNASDAQ:BNTXBioNTech SE
05/21/20244:36PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
05/21/20246:45AMGlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024NASDAQ:BNTXBioNTech SE
05/17/20244:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
05/17/202411:15AMGlobeNewswire Inc.BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024NASDAQ:BNTXBioNTech SE
05/06/20248:09AMIH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:BNTXBioNTech SE
05/06/20247:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
05/06/20246:48AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
05/06/20246:45AMGlobeNewswire Inc.BioNTech Announces First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
04/26/20247:48AMIH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNASDAQ:BNTXBioNTech SE
04/24/20247:28AMIH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNASDAQ:BNTXBioNTech SE
04/22/20246:45AMGlobeNewswire Inc.BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024NASDAQ:BNTXBioNTech SE
04/07/20242:00PMGlobeNewswire Inc.Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic CancerNASDAQ:BNTXBioNTech SE
03/21/20247:17AMIH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNASDAQ:BNTXBioNTech SE
03/20/20247:17AMIH Market NewsU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices DipNASDAQ:BNTXBioNTech SE
03/20/20246:15AMGlobeNewswire Inc.BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
03/20/20246:00AMGlobeNewswire Inc.BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial OfficerNASDAQ:BNTXBioNTech SE
03/11/20249:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
03/11/20247:45AMGlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024NASDAQ:BNTXBioNTech SE
03/11/20246:25AMPR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTXNASDAQ:BNTXBioNTech SE
03/07/20248:41AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
03/07/20246:45AMGlobeNewswire Inc.BioNTech Announces Planned Retirement of Sean MarettNASDAQ:BNTXBioNTech SE
03/06/20246:45AMGlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024NASDAQ:BNTXBioNTech SE
03/05/20245:45AMPR Newswire (US)The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTXNASDAQ:BNTXBioNTech SE
02/28/20246:26PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
02/26/20245:45AMPR Newswire (US)Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BNTXBioNTech SE
02/22/20245:45AMPR Newswire (US)BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTXNASDAQ:BNTXBioNTech SE
 Showing the most relevant articles for your search:NASDAQ:BNTX

Your Recent History

LSE
XWQS
X Quality Esg
BMF
VF3F25C000825
VF3F25C000825 - 01/2025
BIT
S32545
Societe Generale Effekten
BIT
UB27SP
UniCredit Bank
ASX
AHGKOP
ASE
KTILA
Ktima Lazaridis
BIT
AUHEUA
UBS MSCI Australia UCITS...
NASDAQ
HYMCW
Hycroft Mining
NASDAQ
LIND
Lindblad Expeditions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved